Qilian International Holding Group Limited (BGM) - Total Liabilities
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has total liabilities worth $41.68 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Qilian International Holding Group Limit's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Qilian International Holding Group Limited - Total Liabilities Trend (2017–2025)
This chart illustrates how Qilian International Holding Group Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Qilian International Holding Group Limit.
Qilian International Holding Group Limited Competitors by Total Liabilities
The table below lists competitors of Qilian International Holding Group Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RiTdisplay Corp
TW:8104
|
Taiwan | NT$5.23 Billion |
|
Serrano 61 Desarrollo SOCIMI SA
MC:YSRR
|
Spain | €36.97 Million |
|
Chung Fu Tex-International Corp
TW:1435
|
Taiwan | NT$185.59 Million |
|
Immobile
WAR:GKI
|
Poland | zł834.88 Million |
|
Fulin Plastic Industry Cayman Holding Co Ltd
TW:1341
|
Taiwan | NT$1.01 Billion |
|
Catur Sentosa Adiprana Tbk
JK:CSAP
|
Indonesia | Rp8.56 Trillion |
|
Tsang Yow Industrial Co Ltd
TW:1568
|
Taiwan | NT$353.63 Million |
|
Nasmedia Co. Ltd
KQ:089600
|
Korea | ₩185.10 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Qilian International Holding Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Qilian International Holding Group Limit net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qilian International Holding Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qilian International Holding Group Limited (2017–2025)
The table below shows the annual total liabilities of Qilian International Holding Group Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $41.68 Million | +367.73% |
| 2024-09-30 | $8.91 Million | +29.01% |
| 2023-09-30 | $6.91 Million | -27.78% |
| 2022-09-30 | $9.56 Million | -48.82% |
| 2021-09-30 | $18.68 Million | -3.20% |
| 2020-09-30 | $19.30 Million | +52.82% |
| 2019-09-30 | $12.63 Million | -19.13% |
| 2018-09-30 | $15.62 Million | -20.82% |
| 2017-09-30 | $19.73 Million | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more